Hitting the sweet spot: exploiting HIV-1 glycan shield for induction of broadly neutralizing antibodies
Journal Article
·
· Current Opinion in HIV and AIDS
- Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
- Univ. of Pennsylvania, Philadelphia, PA (United States)
- Los Alamos National Lab. (LANL), Los Alamos, NM (United States); New Mexico Consortium, Los Alamos, NM (United States)
The surface of the HIV-1 Env glycoprotein, the target of neutralizing antibodies, is extensively covered by N-linked glycans that create a glycan shield. Broadly neutralizing antibodies (bNAbs), the primary targets of HIV-1 vaccine design, have to negotiate this glycan shield. Here, we review the barriers and opportunities that the HIV-1 glycan shield presents for vaccine induction of bNAbs.
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- USDOE Laboratory Directed Research and Development (LDRD) Program
- Grant/Contract Number:
- 89233218CNA000001
- OSTI ID:
- 1756809
- Report Number(s):
- LA-UR--20-26631
- Journal Information:
- Current Opinion in HIV and AIDS, Journal Name: Current Opinion in HIV and AIDS Journal Issue: 5 Vol. 15; ISSN 1746-630X
- Publisher:
- Wolters Kluwer Health, Inc.Copyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
Journal Article
·
Tue Mar 14 20:00:00 EDT 2017
· Science Translational Medicine
·
OSTI ID:1406204
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability
Journal Article
·
Mon Nov 11 19:00:00 EST 2019
· Immunity
·
OSTI ID:1577147
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
Journal Article
·
Tue Mar 27 20:00:00 EDT 2018
· Nature Communications
·
OSTI ID:1624084